Overexpression of GLUT1 has been frequently associated with the upregulation of CD147 in several types of tumors, such as papillary renal cell carcinoma (pRCC) [52] or cervical squamous cell carcinoma [54], or melanoma, where it affects aerobic glycolysis favoring metabolic reprograming and tumor growth [55]. Here, SLC2A1 is linked to neoplasm.